This week’s Bulls N’ Bears ASX Runner of the Week is… Wide Open Agriculture

ASX Runners:Wide Open Ag,Renergen,Resolution&Metal Powder Works

This week’s Bulls N’ Bears ASX Runner of the Week is… Wide Open Agriculture. Its share price ran on sales of its lupin protein to Europe,Latin America and Australia.

  • Andrew Todd

Latest

Sarytogan Graphite is on the hunt for good quality water supplies for its Kazakh graphite project and is drilling water bores in the Sherubainura River aquifer.

Sarytogan looking to bank water allocation for Kazakh graphite project

Sarytogan Graphite has identified a suitable water resource 14 kilometres northwest of the company’s Kazakhstan graphite project.

  • Doug Bright
Auric Mining is moving ahead with the acquisition of the 200,000-tonnes-per-annum Burbanks gold plant south of Coolgardie in Western Australia.

Auric locks in dirt-cheap WA Burbanks gold plant for $4.4m

Auric Mining has wrapped up due diligence on the Burbanks gold mill in Western Australia and is now preparing to snap up the plant for the bargain price of $4.4m.

  • James Pearson
Whitebark Energy’s takeover of King Energy has become unconditional,allowing the acquisition of its Alinya hydrogen,helium and natural gas project in South Australia’s Officer Basin.

Whitebark seals deal as King Energy takeover becomes unconditional

Whitebark Energy’s takeover bid for King Energy has passed the magic 90% ownership mark to become unconditional,locking in one of Australia’s best onshore 3H plays.

  • Andrew Todd
Assay plates on an automated platform using PromarkerD to test for the early signs of chronic kidney disease in type 2 diabetes patients.

Proteomics launches predictive kidney disease test in Australia

Proteomics International Laboratories has launched its novel PromarkerD test for diabetic kidney disease in WA and the NT before expanding Australia-wide.

  • James Pearson
Metallurgical test work has proved up impressive gold recovery rates at Strickland Metals’ Horse Well camp in Western Australia’s Eastern Goldfields.

Strickland tests notch up big recovery rates at WA gold project

Metallurgical test work by Strickland Metals on the Palomino deposit at its Horse Well gold camp in Western Australia’s northeastern goldfields has notched up whopping gold recovery rates of up to 88.6 per cent.

  • James Pearson
Advertisement
Drilling in progress at Star Minerals’ Tumblegum South gold project in Western Australia. The company is fast-tracking development at site after raising $1.6 million in fresh cash and bringing a strategic investor on board.

Star pivots to WA gold as yellow metal price booms

Star Minerals is fast-tracking plans to mine its 45,000-ounce Tumblegum South gold project in WA after issuing 64m new shares to raise $1.6 million in fresh cash.

  • James Pearson
Lincoln Minerals is kicking off a major program to test un-assayed core after unearthing high-grade base metals at its Minbrie base metals project in South Australia.

Lincoln re-tests old drill core to unlock SA base metal potential

Lincoln Minerals is re-assaying historic core aiming to uncover new base metal potential in South Australia after it was only tested for magnetite in 2011.

  • James Pearson
Sarytogan Graphite has identified a third copper anomaly from aeromagnetics and soil geochemistry at its Sanabi prospect in Kazakhstan,where it has found malachite in silicified felsic rocks.

Sarytogan nets third copper-gold anomaly at new Kazakhstan ground

Sarytogan Graphite has identified a third copper prospect only a year after pegging ground on the western flanks of the Baynazar Caldera in east Kazakhstan.

  • Doug Bright
Results from a trial of Proteomics International Laboratories’ PromarkerD blood test for the detection of chronic kidney disease have been published in a special edition of the peer-reviewed Diagnostics medical journal.

Perth trial proves worth of Proteomics diabetes-related blood test

Proteomics International Laboratories’ PromarkerD blood test has proven to be a step up in predicting chronic kidney disease in a WA-based study of diabetes patients.

  • James Pearson